iLive Connect launched to monitor cardiac activity, reduce mortality
India is confronting a significant cardiovascular burden, with nearly 8,000 deaths occurring daily due to heart disease. Current estimates indicate 10,000 to 15,000 heart attacks per day, with 3,000 to 5,000 resulting in mortality, often without preceding clinical warning.
Cardiovascular and thoracic surgeon Dr Rahul Chandola said this on the occasion of the South India launch of iLive Connect, a device which reduces the risk of sudden cardiac events.
The iLive Connect device has a wearable biosensor patch and wellness bracelets which monitor vital parameters such as heart activity and blood pressure in real time and the system data is tracked 24×7 by experienced doctors at a remote command centre, who alert patients and their families in case of any abnormality.
Around 40 doctors were present at the launch event held in Chennai on Sunday, including Dr Thillai Vallal, Managing Director of Venkateswara Hospitals; Dr M A Raja, Director and Senior Consultant in Medical Oncology at MGM Healthcare; Dr Amit Kumar, Critical Care Physician; Dr Gopala Murugan, Senior Consultant in Interventional Cardiology at MGM Healthcare; Dr Prashanth Krishna, MD of Prashanth Group of Hospitals; Dr Manoj Sivarama Krishnan, Senior Interventional Cardiologist at Kavery Hospital and Dr Dhenesh, Critical Care Physician.
Clinicians are increasingly emphasising that symptom-driven care is insufficient, particularly in the context of the rising incidence of heart attacks among younger and asymptomatic populations.
In response, there is a growing shift toward doctor-led continuous cardiac monitoring platforms such as iLive Connect, which enable longitudinal assessment of cardiovascular physiology and support early risk identification.
Adoption is expanding across South India and nationwide, with clinicians integrating such platforms into routine practice to enhance diagnostic accuracy and continuity of care, said Dr Chandola, founder of iLive connect, while addressing the gathering.
Dr Viveka Kumar, a well-known cardiologist and co-founder of iLive Connect, highlights that such platforms function as a clinical extension beyond hospital settings, enabling physicians to maintain visibility over patient physiology and make data-driven decisions in real time, even in ambulatory environments.
“Real-time physiological data allows earlier recognition of cardiac instability, enabling timely intervention and potentially preventing acute events,” he said.
Beyond cardiac care, the platform is being used in the management of chronic conditions such as diabetes, hypertension, chronic obstructive pulmonary disease (COPD) and asthma, he said.
With India accounting for nearly 20 per cent of global heart attack-related deaths, clinicians are calling for a shift from episodic care to a continuous care model based on preventive monitoring and real-time intervention.
“The future of cardiac care lies in continuous visibility, where early detection and timely intervention can significantly improve outcomes,” Dr Chandola said.
